Skip to main content
Premium Trial:

Request an Annual Quote

SciGene Licenses Invitrogen Reagents

NEW YORK (GenomeWeb News) – SciGene has licensed reagents from Life Technologies division Invitrogen for use in a new sample prep system.

The Sunnyvale, Calif.-based firm said that it would incorporate reagents from Invitrogen's BioPrime Total Genomic Labeling System into a kit for use on SciGene's ArrayPrep Target Preparation System, a new instrument that it is developing for automated labeling, purification, and loading of DNA samples onto microarrays for performing aCGH tests.

Terms of the license were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.